Clinical Trials Browser

INDUSTRY × Stomach Neoplasms × pyrotinib × Clear all

NCT02500199 2021-02-01

Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors

Phase 1 Unknown

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms